Sign inJoin waitlistJoin the waitlist

Christos Vaklavas

Professor · Huntsman Cancer Institute & Hospital

Credentials: · · · · · ·

History

Huntsman Cancer Institute & Hospital · Univ of Utah Sch of Med
Present

Hematology and Medical Oncology
2014–2017
Internal Medicine
2011–2014
Doctor of Medicine
1996–2000

Research

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Case report · Nature Cancer · 2022 · 361 citations
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
Review · Oncotarget · 2017 · 248 citations
Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
Cancer Immunology Research · 2016 · 145 citations

Anna Storniolo
9 papers
William Grizzle
9 papers
AF
Andres Forero-Torres
8 papers
Apostolia Tsimberidou
8 papers
AW
Antonio Wolff
7 papers
ML
Minetta Liu
7 papers
Vandana Abramson
7 papers
Lilja Solnes
6 papers
Lisa Carey
6 papers
Richard Wahl
6 papers
Rita Nanda
6 papers
RC
Roisin Connolly
6 papers

Grants

A Feasibility Trial of Functional Precision Cancer Medicine to Inform Treatment Selection in Metastatic Breast Cancer
National Cancer Institute · R21
Contact PI · $390.9K · Utah State Higher Education System--University of Utah
2022–2025

Clinical trials

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
Principal investigator · Recruiting · Phase 2
University of Utah
2023–2028
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Site PI · Recruiting · Phase 2
QuantumLeap Healthcare Collaborative
2010–2031